Product Introduction:
Tripill 2/500/10 mg Tablet combines three oral antidiabetic agents: Voglibose, Metformin, and Pioglitazone. Voglibose delays glucose absorption in the intestines, Metformin decreases hepatic glucose production and improves insulin sensitivity, and Pioglitazone enhances insulin action at the cellular level. This combination helps achieve better glycemic control in type 2 diabetes patients.
Uses:
Used to control blood sugar levels in adults with type 2 diabetes mellitus, especially when diet and exercise alone are insufficient.
Benefits:
Helps reduce blood glucose levels effectively through multiple mechanisms, improves insulin sensitivity, and reduces post-meal blood sugar spikes. Supports long-term management of diabetes and reduces the risk of complications.
Composition:
Each tablet contains:
-
Voglibose 2 mg
-
Metformin Hydrochloride 500 mg
-
Pioglitazone Hydrochloride 10 mg
Side Effects:
Possible side effects include gastrointestinal discomfort (nausea, diarrhea, abdominal pain), headache, dizziness, weight gain, and rarely, hypoglycemia. Monitor for signs of fluid retention or allergic reactions.
Safety Advice:
Use under medical supervision. Not recommended during pregnancy or breastfeeding. Inform your doctor about any liver, kidney, or heart conditions before use. Regular blood sugar monitoring is essential. Take with meals to reduce gastrointestinal side effects. Store in a cool, dry place away from direct sunlight.
